EarningsQ2 2025 Earnings Report

Crispr Therapeutics AG (CRSPN) Q2 2025 Earnings Report

0 Followers

MX:CRSPN Q2 2025 EPS Results

Actual EPS-$44.19

Consensus EPS-$25.82

Beat/MissMissed by -$18.38

One Year Ago EPS-$27.44

Actual Revenue$16.43M

Expected Revenue$113.08M

Beat/MissMissed by -$96.66M

YoY Revenue Growth+72.53%

QuarterQ2 2025

Date08/04/2025

TimeAfter Close

Conference CallMonday, August 4, 2025

MX:CRSPN Upcoming Earnings

Crispr Therapeutics AG's next earnings date is estimated for November 4, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 04, 2026	2026 (Q3)	-19.10 / -	-21.545	―
Aug 03, 2026	2026 (Q2)	-22.00 / -17.31	-44.194	60.83% (+26.88)
May 04, 2026	2026 (Q1)	-22.43 / -23.57	-29.094	18.99% (+5.52)
Feb 12, 2026	2025 (Q4)	-21.42 / -25.23	-8.102	-211.36% (-17.13)
Nov 10, 2025	2025 (Q3)	-23.29 / -21.54	-18.598	-15.84% (-2.95)
Aug 04, 2025	2025 (Q2)	-25.82 / -44.19	-27.437	-61.07% (-16.76)
May 06, 2025	2025 (Q1)	-22.91 / -29.09	-26.332	-10.49% (-2.76)
Feb 11, 2025	2024 (Q4)	-22.12 / -8.10	20.256	-140.00% (-28.36)
Nov 05, 2024	2024 (Q3)	-25.93 / -18.60	-25.964	28.37% (+7.37)
Aug 05, 2024	2024 (Q2)	-26.28 / -27.44	-18.046	-52.04% (-9.39)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed